BIZTRAC BETA
Research and experimental development on natural sciences and engineering

FARMAKON AS

Org. no. 930476676 Limited company (AS) Nordre Follo Incorporated 2022 Active
Ownership graph ↗
Revenue 2025 NOK 1.8m
Operating profit NOK 287,000
Equity NOK 571,000
Incorporated 2022
Share capital NOK 30,000

FARMAKON AS is registered as a limited company in Nordre Follo, Akershus with organisation number 930476676. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2022. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Selge tjenester og varer innen Life science og annet som naturlig sammenfaller med dette, samt deltakelse i andre selskaper, investeringer og nærliggende virksomhet.”. The most recent filed accounts, for the 2025 financial year, show NOK 1.8m in revenue and NOK 287,000 in operating profit.

Key figures · 2025

Revenue
NOK 1.8m
Operating profit
NOK 287,000
Equity
NOK 571,000
Est. value
NOK 1.7m

Financial health · 2025

Liquidity
2.24
Very good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
54.4%
Very good
Equity as a share of total capital

Who owns FARMAKON AS?

SKARE HOLDINGS AS
FARMAKON AS
NOK 1.8m rev. · NOK 287,000 profit

FARMAKON AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about FARMAKON AS

Who owns FARMAKON AS?

SKARE HOLDINGS AS is the largest registered owner, with 100.0%.

What is the revenue of FARMAKON AS?

FARMAKON AS had revenue of NOK 1.8m in 2025.

Who is the general manager of FARMAKON AS?

Ole Christian Skare is registered as general manager of FARMAKON AS.

Where is FARMAKON AS based?

FARMAKON AS has its business address in Sofiemyr.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.